The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acceleron Pharma Inc. | COM | 00434H108 | 10,472 | 254,923 | SH | SOLE | 254,923 | 0 | 0 | ||
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 57,637 | 1,950,477 | SH | SOLE | 1,950,477 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 13,476 | 647,254 | SH | SOLE | 647,254 | 0 | 0 | ||
| Alder BioPharmaceuticals, Inc. | COM | 014339105 | 34,629 | 2,942,130 | SH | SOLE | 2,942,130 | 0 | 0 | ||
| Arcus Biosciences, Inc. | COM | 03969F109 | 10,867 | 1,366,973 | SH | SOLE | 1,366,973 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 23,501 | 204,088 | SH | SOLE | 204,088 | 0 | 0 | ||
| Audentes Therapeutics, Inc. | COM | 05070R104 | 11,938 | 315,331 | SH | SOLE | 315,331 | 0 | 0 | ||
| BioDelivery Sciences International, Inc. | COM | 09060J106 | 2,114 | 454,656 | SH | SOLE | 454,656 | 0 | 0 | ||
| Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 2,857 | 65,249 | SH | SOLE | 65,249 | 0 | 0 | ||
| Blueprint Medicines Corporation | COM | 09627Y109 | 44,116 | 467,682 | SH | SOLE | 467,682 | 0 | 0 | ||
| CymaBay Therapeutics, Inc. | COM | 23257D103 | 11,364 | 1,587,101 | SH | SOLE | 1,587,101 | 0 | 0 | ||
| Epizyme, Inc. | COM | 29428V104 | 12,528 | 998,278 | SH | SOLE | 998,278 | 0 | 0 | ||
| Immunomedics, Inc. | COM | 452907108 | 26,889 | 1,938,612 | SH | SOLE | 1,938,612 | 0 | 0 | ||
| Myokardia, Inc. | COM | 62857M105 | 15,764 | 314,400 | SH | SOLE | 314,400 | 0 | 0 | ||
| Natera, Inc. | COM | 632307104 | 7,901 | 286,468 | SH | SOLE | 286,468 | 0 | 0 | ||
| Replimune Group, Inc. | COM | 76029N106 | 11,430 | 779,656 | SH | SOLE | 779,656 | 0 | 0 | ||
| Tocagen, Inc. | COM | 888846102 | 3,795 | 568,054 | SH | SOLE | 568,054 | 0 | 0 | ||
| WAVE Life Sciences Ltd. | SHS | Y95308105 | 3,650 | 139,900 | SH | SOLE | 139,900 | 0 | 0 | ||